Coca-Cola Hellenic Bottling Company or simply Coca-Cola HBC withdrew its beverages in Croatia while the officials are investigating mysterious illnesses that are suspected to have been caused by the products.
According to Reuters, the state inspection office in the region ordered the Coca-Cola HBC bottling company to take back some batches of two soft drinks brands. On Wednesday, Nov. 8, the officials asked the Croatian unit of the Coca-Cola Company to stop the sake of the specified products as well.
Coca-Cola to Comply With the Order
Coca-Cola HBC which distributes the brand’s products in the country released a statement following the order from the inspection office. In the note that was published by local media, the company said it carried out an internal check but did not find any irregularities in its drinks, the Irish Independent reported.
The Coke maker said that despite its findings, it would still follow the order and withdraw the batches until the state’s probe is completed.
What Sparked the Probe on Coca-Cola’s Soft Drinks
Based on the reports, an investigation was carried out after a young man from the town of Rijeka suddenly complained of throat injuries after drinking a flavored Coca-Cola mineral drink in a cafe. He was immediately brought to the hospital and while still being treated, six more individuals with suspected similar cases showed up in other locations which are the towns of Varazdin and Zagreb.
The country’s health minister, Vili Beros, confirmed the cases of all the individuals. He said that all have been examined in a medical facility but most of them were already sent home.
Finally, the health official said they did not find a direct connection with the cases yet and analysis of drink samples is still ongoing but they expect to get the results soon. The products that were temporarily withdrawn by Coca-Cola HBC Croatia are one batch of Coca-Cola Original Taste in 500 ml. bottles and two batches of Romerquelle Emotion Blueberry Pomegranate in 330 ml. containers.
Photo by: Steve Buissinne/Pixabay


Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Jetstar to Charge for Overhead Cabin Bags From February
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Apple Restores Telegram to App Store After Content Policy Violation
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 



